FIELD: medicine.
SUBSTANCE: method involves venous blood sampling and immunological analysis, wherein the solid-phase chemoluminiscent analysis on microparticles is used to determine the blood serum follicle-stimulating hormone and oestradiol content; K=CO/CFSH, wherein: CFSH is the follicle-stimulating hormone content, mUnit/ml; CO is the oestradiol content, pmole/l. If the numerical value K is more or less 53, using the aromatase inhibitors in treating idiopathic sterility in the males suffering obesity is predicted to be effective.
EFFECT: predicting the clinical effectiveness in idiopathic sterility in the males with suffering obesity using the aromatase inhibitors.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF DISTURBED FERTILITY IN MALES SUFFERING OBESITY | 2012 |
|
RU2498314C1 |
| METHOD OF PREDICTION OF CLINICAL EFFECTIVENESS OF TREATMENT WITH CHORIONIC GONADOTROPIN IN MALES WITH HYPOGONADISM | 2015 |
|
RU2604681C1 |
| METHOD FOR PREDICTION OF EFFICIENCY OF LOW-INTENSITY LASER THERAPY IN SECRETARY TERATOZOSPERMIA | 2021 |
|
RU2759539C1 |
| METHOD OF TREATING OBSTRUCTIVE AZOOSPERMIA AND CRYPTOZOOSPERMIA IN PATIENTS WITH CHRONIC PROSTATITIS | 2015 |
|
RU2586305C1 |
| METHOD FOR FORECASTING EFFICIENCY OF LOW-INTENSITY LASER THERAPY IN SECRETORY ASTENOZOSPERMIA | 2020 |
|
RU2748895C1 |
| METHOD OF TREATING PATIENTS SUFFERING FROM CHRONIC PROSTATITIS WITH PARTIAL ANDROGEN DEFICIENCY | 2013 |
|
RU2525182C1 |
| METHOD OF TREATING HYPOGONADOTROPIC HYPOGONADISM, NASAL SPRAY AS METHOD FOR ADMINISTERING GONADORELIN ACETATE IN TREATING HYPOGONADOTROPIC HYPOGONADISM | 2019 |
|
RU2733465C1 |
| DIAGNOSTIC TECHNIQUE FOR HORMONAL DISORDERS IN MEN | 2019 |
|
RU2715565C1 |
| METHOD FOR AROMATASE ACTIVITY TEST | 2012 |
|
RU2481587C1 |
| METHOD FOR INTEGRATED TREATMENT OF PATHOZOOSPERMIA IN MALES SUFFERING ADRENAL HYPERANDROGENISM | 2012 |
|
RU2510284C1 |
